Drug Type Small molecule drug |
Synonyms A-420983 |
Target |
Action inhibitors |
Mechanism LCK inhibitors(Tyrosine-protein kinase LCK inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H39N9O2 |
InChIKeySTVKLDUINKMZFE-RQNOJGIXSA-N |
CAS Registry330789-03-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graft Rejection | Preclinical | United States | 01 May 2004 |





